Literature DB >> 12809111

State Medicaid coverage for tobacco-dependence treatments--United States, 1994-2001.

.   

Abstract

Tobacco use is the leading preventable cause of death in the United States. One of the national health objectives for 2010 is to increase insurance coverage of evidence-based treatment for nicotine dependence (i.e., total coverage of behavioral therapies and Food and Drug Administration [FDA]--approved pharmacotherapies) in Medicaid programs from 36 states to all states and the District of Columbia (DC) (objective 27.8). To increase both the use of treatment by smokers attempting to quit and the number of smokers who quit successfully, the Guide to Community Preventive Services recommends reducing the "out-of-pocket" cost of effective tobacco-dependence treatments (i.e., individual, group, and telephone counseling, and FDA--approved pharmacotherapies) for smokers. The 2000 Public Health Service (PHS) Clinical Practice Guideline supports expanded insurance coverage for tobacco-dependence treatments. In 2000, approximately 32 million low-income persons in the United States received their health insurance coverage through the federal-state Medicaid program; 11.5 million (36%) of these persons smoked (CDC, unpublished data, 2000). The amount and type of coverage for tobacco-dependence treatment offered by Medicaid has been reported for 1998 and 2000 from state surveys conducted by the Center for Health and Public Policy Studies (CHPPS) at the University of California, Berkeley. All states and DC were re-surveyed in 2001 about amount and type of coverage, and level of coverage since 1994. This report summarizes the results of the survey, which indicate that the number of Medicaid programs providing some coverage for tobacco-dependence counseling or medication increased from 34 in 2000 to 36 in 2001, but only one state offered coverage for all the counseling and pharmacotherapy treatments recommended by the 2000 PHS guideline. If the 2010 national health objective is to be achieved, Medicaid coverage for treatment of tobacco dependence should be increased dramatically.

Entities:  

Mesh:

Year:  2003        PMID: 12809111

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

Review 1.  The role of research in international tobacco control.

Authors:  Kenneth E Warner
Journal:  Am J Public Health       Date:  2005-06       Impact factor: 9.308

2.  Can a Computer-Based Prescription of Free Medication Increase Smoking Cessation Rates Efficiently?

Authors:  Banu Salepci; Ali Fidan; Benan Çağlayan; Elif Torun Parmaksız; Nesrin Kıral; Sevda Şener Cömert; Gülten Aktin Güngör; Egehan Salepci
Journal:  Turk Thorac J       Date:  2015-12-14

3.  Expansion of Medicaid covered smoking cessation services: maternal smoking and birth outcomes.

Authors:  E Kathleen Adams; Sara Markowitz; Patricia M Dietz; Van T Tong
Journal:  Medicare Medicaid Res Rev       Date:  2013-06-08

4.  Medicaid enrollment policy increased smoking cessation among pregnant women but had no impact on birth outcomes.

Authors:  Marian Jarlenski; Sara N Bleich; Wendy L Bennett; Elizabeth A Stuart; Colleen L Barry
Journal:  Health Aff (Millwood)       Date:  2014-06       Impact factor: 6.301

5.  Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008.

Authors:  Jennifer Kahende; Ann Malarcher; Lucinda England; Lei Zhang; Paul Mowery; Xin Xu; Varadan Sevilimedu; Italia Rolle
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.